Refine by
Drug Attached Equipment & Supplies
7 equipment items found
Manufactured by:Applied Membrane Technology, Inc. based inMinnetonka, MINNESOTA (USA)
Applied Membrane Technology (AMT) offers custom surface coated membranes and microporous beads tailored to your diagnostic ...
Manufactured by:ApiJect Systems, Corp. based inStamford, CONNECTICUT (USA)
The ApiJect Platform brings together prefilled, single-dose parenterals with scalable, efficient manufacturing to solve drug delivery challenges for sterile liquid pharmaceuticals in all markets. ...
by:Starpharma Holdings Limited based inMelbourne, AUSTRALIA
Starpharma’s DEP® technology provides enhanced therapeutic benefits to Antibody Drug Conjugates (ADCs) including greater homogeneity, site specific attachment, and higher drug antibody ratio (DAR), than conventional ADC approaches. The use of ADCs is an innovative and cutting-edge area in cancer therapy that continues to grow, and ...
Manufactured by:PolyActiva Pty Ltd. based inParkville, AUSTRALIA
For development of best-in-class ocular implants that deliver the right amount of drug, for the right period. Our technology is based on extensive scientific research leveraging our expertise in pharmaceutical, organic and polymer chemistry. The result is the creation of a unique method for precise and controlled drug delivery. Since many eye diseases are lifelong chronic disorders, a reliable ...
Manufactured by:Mablink Bioscience based inLyon, FRANCE
Antibody–drug conjugates (ADCs) are a unique class of targeted immuno-oncology therapeutics that combine the tumor-targeting selectivity, stability, and favorable pharmacokinetic profile of monoclonal antibodies, with the potent antitumor activity of cytotoxic drugs. The ultimate goal of ADCs is to increase the therapeutic index of potent chemical agents, by the selective delivery of the ...
by:Starpharma Holdings Limited based inMelbourne, AUSTRALIA
Starpharma uses its proprietary dendrimers in two different ways: as therapeutics themselves (e.g. SPL7013/VivaGel®) or by using the dendrimer scaffold (DEP®) with covalently attached drug molecules (DEP® conjugate) to improve the performance of those existing drugs. ...
Manufactured by:Mersana Therapeutics based inCambridge, MASSACHUSETTS (USA)
The Dolaflexin platform was designed to increase the efficacy, safety, and tolerability of ADCs. This platform overcomes the limitations of traditional ADCs in which drugs are directly conjugated to antibodies. Dolaflexin utilizes our proprietary Fleximer polymer, a biodegradable, highly biocompatible, water-soluble polymer able to carry multiple drug molecules. ...